Regencell Bioscience (RGC) has had the highest return since May 24, 2021 by a mid-cap US stock, returning 4,054.5%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 4,054.53% |
Sezzle Inc Common Stock (SEZL) | 2,333.64% |
Triumph (TGI) | 1,791.12% |
Trump Media & Technology (DJTWW) | 1,701.49% |
Verona Pharma PLC ADR (VRNA) | 1,696.42% |
Vista Oil Gas ADR (VIST) | 1,169.11% |
Sterling Construction (STRL) | 1,139.76% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 867.87% |
ADMA Biologics (ADMA) | 865.34% |
Liquidia Technologies (LQDA) | 779.66% |
Centrus Energy (LEU) | 726.17% |
Modine Manufacturing (MOD) | 724.73% |
Powell Industries (POWL) | 682.94% |
Grupo Financiero Galicia SA ADR (GGAL) | 624.68% |
BBVA Banco Frances SA ADR (BBAR) | 588% |
Viking Therapeutics (VKTX) | 566.06% |
IES (IESC) | 541.86% |
Alliance Resource Partners (ARLP) | 512.4% |
Transportadora de Gas del Sur SA ADR (TGS) | 508.03% |
Abivax SA American Depositary Shares (ABVX) | 507.24% |
Banco Macro SA B ADR (BMA) | 499.19% |
Stride (LRN) | 472.52% |
MoonLake Immunotherapeutics (MLTX) | 445.81% |
Hawkins (HWKN) | 445.07% |
Belite Bio Inc ADR (BLTE) | 433.04% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
